Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer by Coralie Poulard, Thuy Ha Pham, Youenn Drouet, Julien Jacquemetton, Ausra Surmielova, Loay Kassem, Benoite Mery, Christine Lasset, Jonathan Reboulet, Isabelle Treilleux, Elisabetta Marangoni, Olivier Trédan, Muriel Le Romancer

Get full text

Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy by Olivia Le Saux, Renaud Sabatier, Isabelle Treilleux, Léa-Isabelle Renaud, Pierre-Emmanuel Brachet, Alejandra Martinez, Jean-Sébastien Frenel, Cyril Abdeddaim, Justine Berthet, Sarah Barrin, Amélie Colombe-Vermorel, Laetitia Odeyer, Alexandra Lainé, Christophe Caux, Bertrand Dubois, Isabelle Ray-Coquard

Get full text

HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer by Qing Wang, Maha Ayyoub, Olivia Le Saux, Paola Bonaventura, Isabelle Treilleux, Nicolas Chopin, Clarisse Dubois, Virginie Mutez, Nicolas Chuvin, Yann Estornes, Jenny Valladeau-Guilemond, Stephane Depil, Nicolas Gadot, Marie Michelas, Audrey Page, Olivier Tabone, Marie Delles, Sarah Moran, Thibault Richard, Marjorie Lacourrège, Dina M Tawfik, Ema Etchegaray, Adrian Valente, Rasha E Boulos, Gabriel Jimenez Dominguez

Get full text